UBS Group’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-403,874
| Closed | -$6.16M | – | 10626 |
|
|
2025
Q4 | $6.16M | Sell |
403,874
-25,047
| -6% | -$373K | ﹤0.01% | 3810 |
|
|
2025
Q3 | $6.39M | Sell |
428,921
-16,252
| -4% | -$236K | ﹤0.01% | 3785 |
|
|
2025
Q2 | $6.38M | Sell |
445,173
-51,191
| -10% | -$712K | ﹤0.01% | 3617 |
|
|
2025
Q1 | $7.19M | Sell |
496,364
-240,321
| -33% | -$3.62M | ﹤0.01% | 3403 |
|
|
2024
Q4 | $11.1M | Sell |
736,685
-32,028
| -4% | -$485K | ﹤0.01% | 2925 |
|
|
2024
Q3 | $11.4M | Sell |
768,713
-25,793
| -3% | -$370K | ﹤0.01% | 2246 |
|
|
2024
Q2 | $11.1M | Buy |
794,506
+9,325
| +1% | +$131K | ﹤0.01% | 2127 |
|
|
2024
Q1 | $11.5M | Buy |
785,181
+12,389
| +2% | +$179K | ﹤0.01% | 2152 |
|
|
2023
Q4 | $10.8M | Sell |
772,792
-42,697
| -5% | -$582K | ﹤0.01% | 2026 |
|
|
2023
Q3 | $11.2M | Buy |
815,489
+17,342
| +2% | +$245K | ﹤0.01% | 1904 |
|
|
2023
Q2 | $11.3M | Buy |
798,147
+22,752
| +3% | +$330K | ﹤0.01% | 1880 |
|
|
2023
Q1 | $11.4M | Buy |
775,395
+5,142
| +0.7% | +$78.1K | ﹤0.01% | 1801 |
|
|
2022
Q4 | $11.9M | Sell |
770,253
-1,938
| -0.3% | -$29.4K | ﹤0.01% | 1793 |
|
|
2022
Q3 | $10.4M | Buy |
772,191
+15,606
| +2% | +$242K | ﹤0.01% | 1753 |
|
|
2022
Q2 | $11.6M | Buy |
756,585
+37,806
| +5% | +$605K | ﹤0.01% | 1703 |
|
|
2022
Q1 | $11.9M | Buy |
718,779
+7,034
| +1% | +$118K | ﹤0.01% | 1804 |
|
|
2021
Q4 | $12.6M | Sell |
711,745
-7,188
| -1% | -$125K | ﹤0.01% | 1947 |
|
|
2021
Q3 | $12M | Buy |
718,933
+23,508
| +3% | +$406K | ﹤0.01% | 1891 |
|
|
2021
Q2 | $11.8M | Buy |
695,425
+39,963
| +6% | +$672K | ﹤0.01% | 1895 |
|
|
2021
Q1 | $10.7M | Sell |
655,462
-29,913
| -4% | -$460K | ﹤0.01% | 1899 |
|
|
2020
Q4 | $10.4M | Sell |
685,375
-18,186
| -3% | -$260K | ﹤0.01% | 1814 |
|
|
2020
Q3 | $9.52M | Sell |
703,561
-17,775
| -2% | -$245K | ﹤0.01% | 1677 |
|
|
2020
Q2 | $9.82M | Sell |
721,336
-170,793
| -19% | -$2.28M | ﹤0.01% | 1526 |
|
|
2020
Q1 | $11.2M | Sell |
892,129
-150,225
| -14% | -$2.41M | 0.01% | 1325 |
|
|
2019
Q4 | $18.4M | Sell |
1,042,354
-28,107
| -3% | -$500K | 0.01% | 1442 |
|
|
2019
Q3 | $19.1M | Buy |
1,070,461
+54,508
| +5% | +$961K | 0.01% | 1274 |
|
|
2019
Q2 | $17.9M | Buy |
1,015,953
+24,117
| +2% | +$425K | 0.01% | 1285 |
|
|
2019
Q1 | $17.9M | Buy |
991,836
+81,414
| +9% | +$1.43M | 0.01% | 1209 |
|
|
2018
Q4 | $14.7M | Sell |
910,422
-63,720
| -7% | -$1.14M | 0.01% | 1293 |
|
|
2018
Q3 | $19.3M | Buy |
974,142
+162,589
| +20% | +$3.12M | 0.01% | 1230 |
|
|
2018
Q2 | $15M | Buy |
811,553
+80,228
| +11% | +$1.51M | 0.01% | 1384 |
|
|
2018
Q1 | $13M | Sell |
731,325
-38,495
| -5% | -$707K | 0.01% | 1476 |
|
|
2017
Q4 | $14.5M | Buy |
769,820
+24,410
| +3% | +$436K | 0.01% | 1419 |
|
|
2017
Q3 | $12.6M | Sell |
745,410
-47,292
| -6% | -$789K | 0.01% | 1425 |
|
|
2017
Q2 | $13.1M | Buy |
792,702
+5,322
| +0.7% | +$86.1K | 0.01% | 1317 |
|
|
2017
Q1 | $12.3M | Buy |
787,380
+45,533
| +6% | +$713K | 0.01% | 1331 |
|
|
2016
Q4 | $11.1M | Buy |
741,847
+179,322
| +32% | +$2.61M | 0.01% | 1417 |
|
|
2016
Q3 | $8.11M | Buy |
562,525
+97,240
| +21% | +$1.42M | ﹤0.01% | 1597 |
|
|
2016
Q2 | $6.76M | Buy |
465,285
+57,513
| +14% | +$815K | ﹤0.01% | 1694 |
|
|
2016
Q1 | $5.75M | Buy |
407,772
+53,132
| +15% | +$713K | ﹤0.01% | 1749 |
|
|
2015
Q4 | $5.09M | Buy |
354,640
+50,589
| +17% | +$721K | ﹤0.01% | 1948 |
|
|
2015
Q3 | $4.1M | Sell |
304,051
-2,996
| -1% | -$42.9K | ﹤0.01% | 2083 |
|
|
2015
Q2 | $4.56M | Buy |
307,047
+18,269
| +6% | +$277K | ﹤0.01% | 2172 |
|
|
2015
Q1 | $4.38M | Buy |
288,778
+12,882
| +5% | +$199K | ﹤0.01% | 2185 |
|
|
2014
Q4 | $4.25M | Buy |
+275,896
| New | +$4.44M | ﹤0.01% | 2237 |
|
Other funds holding DIAX
UBS Group's DIAX Position: Q1 2026 in Review
UBS Group sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 403,874 shares — an estimated $6.16M sold.
UBS Group first reported a position in DIAX in Q4 2014 and held it in 45 quarters. The position peaked at $19.3M in Q3 2018. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.
- UBS Group reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 403,874 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $6.16M.
- UBS Group first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 45 quarters.
- UBS Group's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $19.3M in Q3 2018.
- 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.